SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-032671
Filing Date
2022-02-09
Accepted
2022-02-09 16:08:05
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d277246d424b5.htm 424B5 419077
2 GRAPHIC g277246g01a33.jpg GRAPHIC 58099
3 GRAPHIC g277246g04f41.jpg GRAPHIC 46601
  Complete submission text file 0001193125-22-032671.txt   560388
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-239706 | Film No.: 22607259
SIC: 2834 Pharmaceutical Preparations